BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

Graham Capital Management, L.P.'s Holding History (CIK: 0001315421)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 83,876 Value ($000) $654 Avg Close $7.23 Range $6.00 - $8.17
Q3 2025
Shares 267,730 Value ($000) $2,032 Avg Close $8.33 Range $7.42 - $9.23
Q2 2025
Shares 219,084 Value ($000) $1,963 Avg Close $9.31 Range $6.02 - $11.31
Q1 2025
Shares 136,103 Value ($000) $1,021 Avg Close $8.07 Range $6.96 - $9.50
Q4 2024
Shares 97,257 Value ($000) $731 Avg Close $7.59 Range $6.85 - $8.44
Q4 2023
Shares 64,856 Value ($000) $388 Avg Close $5.79 Range $4.83 - $7.06
Q3 2023
Shares 37,526 Value ($000) $266 Avg Close $7.18 Range $6.62 - $7.95
Q2 2023
Shares 37,637 Value ($000) $265 Avg Close $8.02 Range $6.87 - $9.07
Q3 2022
Shares 24,972 Value ($000) $314 Avg Close $12.87 Range $10.33 - $15.43
Q2 2022
Shares 162,713 Value ($000) $1,721 Avg Close $10.32 Range $7.61 - $18.00